Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoquercetin in mild-to-moderate hospitalized COVID-19
NCT04733651Phase 2Unknown
- Sponsor
- Nepal Health Research Council
- Start
- Feb 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of isoquercetin in coronavirus disease 2019 (COVID-19), sponsored by Nepal Health Research Council. Status: unknown.
02
Drugs
isoquercetin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04733651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04733651.